SCHEMBL16416575

SCHEMBL16416575

CCOC(=O)CS(=O)(=O)C1CN(C(=O)O)C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ GAA P10253 5/20 0.35
▸ MGAM O43451 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21098109 0.83 KMT2A (0.38) TSHRLMNAPOLBKMT2AALDH1A1
SCHEMBL16415500 0.81 NR1H2 (0.43) TSHRKMT2AALDH1A1L3MBTL1MAPT
SCHEMBL16416153 0.79 ATM (0.37) TSHRLMNAPOLBKMT2AALDH1A1
SCHEMBL21639937 0.79 CHRNB2 (0.33) KMT2A
SCHEMBL21798224 0.76 KMT2A (0.40) TSHRPOLBKMT2AALDH1A1GAA
SCHEMBL21798169 0.76 KMT2A (0.41) TSHRLMNAPOLBKMT2AALDH1A1
SCHEMBL21798249 0.75 KMT2A (0.39) TSHRLMNAPOLBKMT2AALDH1A1
SCHEMBL29086022 0.74 GAA (0.45) TSHRPOLBKMT2AALDH1A1GAA
SCHEMBL18497368 0.73 TSHR (0.41) TSHRLMNAPOLBKMT2AALDH1A1
SCHEMBL21797973 0.72 POLB (0.41) TSHRLMNAPOLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015011252-A1 PYRIMIDINE-PYRIDINONE SERINE/THREONINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2015-01-29 — — WO disclosed
Send feedback